Polygenic Risk Score Testing Market, By Service Type, By Sample Type, By Disease Category, By Application, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Polygenic Risk Score Testing Market size was valued at US$ 1,600.51 Million in 2025, expanding at a CAGR of 15.89% from 2026 to 2033.

Polygenic Risk Score (PRS) testing is an advanced genetic assessment method that analyzes multiple genetic variants to estimate an individual's risk of developing complex diseases. It is widely used in healthcare for applications such as disease risk prediction, preventive screening, and personalized treatment planning. The Polygenic Risk Score (PRS) testing market includes advanced analytical methods that evaluate an individual's likelihood of developing complex diseases using multiple genetic markers. For instance, in 2025 , the study by NIH.gov highlights that modern genome-wide association research now evaluates tens of thousands of genetic markers (often 10,000-50,000+ SNPs per study) to identify associations with complex diseases such as cancer, cardiovascular disorders, and autoimmune conditions. These methods analyze gene sets of 20-100+ SNPs per pathway or cluster, improving the detection of weak genetic signals. Therefore, growing, the genomic complexity and multi-marker analysis are driving the adoption of PRS testing in precision medicine.

Polygenic Risk Score Testing Market- Market Dynamics

Rising awareness to propel market demand for precision medicine growth

The rising demand for precision medicine is driving the growth of Polygenic Risk Score Testing market, as it enables more accurate prediction of disease risk based on individual genetic profiles, leading to improved prevention and personalized treatment outcomes. For instance, the NAM Org. report highlights that precision medicine is rapidly expanding through the integration of large-scale genomic and clinical datasets, enabling personalized treatment selection. Early clinical use shows that about 1 in 5 patients undergoing precision-based interventions experience changes in therapy decisions, while genomic studies achieve diagnostic yields of around 30-35% in previously undiagnosed conditions. The report highlights that precision medicine is increasingly driven by the rapid expansion of multi-omics data and real-world health databases across healthcare systems. As the expanding precision medicine and genomic-driven care are driving PRS testing market growth.

Recent advances in precision medicine highlight the growing use of AI and multimodal data integration to improve disease prediction, diagnosis, and treatment selection. Precision oncology is also expanding through targeted therapies, liquid biopsy technologies, and advanced cancer profiling techniques. In addition, multi-omics and spatial medicine approaches are enabling deeper insights into disease behavior at the cellular level.

Polygenic Risk Score Testing Market- Segmentation Analysis:

The Global Polygenic Risk Score Testing Market is segmented on the basis of Service Type, Sample Type, Disease Category, Application, End User, and Region.

In Polygenic Risk Score Testing market, genotyping services hold a significant share due to their cost-effectiveness, scalability, and widespread use in analyzing genetic variants for disease risk assessment across clinical and research applications. In March 2025, 23andMe expanded its genotyping services by enhancing its consumer genetic testing platform, including its 23andMe+(TM) Premium Membership and 23andMe Health + Ancestry Service, focusing on improved polygenic risk score insights for disease prediction and personalized health reporting. Hence, genotyping services continue to play a key role in Polygenic Risk Score Testing market due to their affordability, scalability, and growing use in advanced disease risk prediction and personalized healthcare.

The cardiovascular diseases segment holds a significant share in Polygenic Risk Score Testing market, as these conditions are highly prevalent and benefit from early risk prediction through genetic analysis, enabling preventive care and improved disease management. For instance, in 2026, the JACC Org. cardiovascular statistics report highlights that hypertension affects nearly 1 in 2 U.S. adults (≈50%), making it one of the most prevalent cardiovascular risk factors. The study also shows that obesity now impacts over 40% of the adult population, reflecting a strong upward trend in risk burden. In addition, heart failure affects approximately 6.7 million adults, while coronary heart disease impacts more than 20 million people in the U.S.

Polygenic Risk Score Testing Market- Geographical Insights

Among geographical regions, North America holds a prominent position in Polygenic Risk Score Testing market, supported by advanced genomic infrastructure and strong government funding. Growth in the region is driven by expanding precision medicine programs and rising use of genetic risk assessment tools. For instance, in April 2025, the US government reported that genetic improvement technologies are increasingly adopted across research and applied breeding programs, with modern genomic selection approaches enabling analysis of tens of thousands to over 50,000 genetic markers (SNPs) per individual for trait prediction and improved selection accuracy. Therefore, North America maintains a key position in the market, driven by advanced genomics, precision medicine, and widespread adoption of genetic analysis.

Japan Polygenic Risk Score Testing Market- Country Insights

Japan is witnessing growth in Polygenic Risk Score Testing market, driven by its advanced healthcare infrastructure, increasing focus on precision medicine, and rising demand for early disease risk prediction using genetic analysis across clinical and research applications. For instance, according to JMIR.org, a nationwide survey in Japan covering approximately 40,000 screened participants found that only 5.29% (1,956 of 36,998 respondents) had experienced online medical care, highlighting significant untapped potential for clinical adoption. Among healthcare institutions surveyed, only 20.4% of healthcare institutions had adopted online medical care services, while most still depend on traditional care models. Japan's PRS testing market shows strong growth potential driven by precision medicine and genetic healthcare adoption despite low digital care uptake.

Polygenic Risk Score Testing Market- Competitive Landscape:

Polygenic Risk Score Testing market is highly competitive, driven by advancements in genomic technologies, increasing demand for personalized healthcare, and continuous innovation in genetic risk assessment solutions. Leading companies such as 23andMe, Myriad Genetics, Color Genomics, Quest Diagnostics, and Illumina are focusing on expanding their genotyping and sequencing capabilities, strengthening data analytics platforms, and enhancing clinical utility to maintain their market position. In March 2025, Color Health (formerly Color Genomics) expanded its strategic collaborations with major U.S. research and healthcare institutions, strengthening its role in large-scale genomic screening programs that integrate polygenic risk score-based insights into preventive cancer and hereditary disease risk assessment initiatives. Therefore, innovation and collaborations are driving the adoption of polygenic risk score testing in personalized healthcare.

Recent Developments:

In March 2025, Quest Diagnostics expanded its genomics and precision health capabilities by acquiring select assets of genetic testing and risk assessment platforms, strengthening its position in polygenic risk score and advanced disease prediction services for clinical and population health applications.

In January 2025, Illumina expanded its Polygenic Risk Score Software-Predict Module within BaseSpace Sequence Hub, enabling improved genotype-to-risk analysis, ancestry-aware risk prediction, and streamlined reporting for complex disease risk assessment across research and precision health applications.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POLYGENIC RISK SCORE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

23andMe
Myriad Genetics
Color Genomics
Quest Diagnostics
Illumina
Invitae Corporation
F. Hoffmann-La Roche
Thermo Fisher Scientific
Eurofins Scientific
BGI Genomics
Ambry Genetics
Centogene
Natera
QIAGEN
Personalis
Others

GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2020 - 2033

Sequencing Services
Genotyping Services
Data Analysis and Interpretation
Software / Platforms
Reporting Solutions
Others

GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033

Saliva
Buccal Swab
Blood
Others

GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY DISEASE CATEGORY- MARKET ANALYSIS, 2020 - 2033

Cancer
Cardiovascular Diseases
Neurodegenerative Disorders
Genetic Diseases
Others

GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

Disease Risk Assessment
Research
Personalized Medicine
Others

GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

Hospitals and Clinics
Research Institutes
Pharmaceutical and Biotech Companies
Others

GLOBAL POLYGENIC RISK SCORE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6435

1. Polygenic Risk Score Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Polygenic Risk Score Testing Market Snippet by Service Type
- 2.1.2. Polygenic Risk Score Testing Market Snippet by Sample Type
- 2.1.3. Polygenic Risk Score Testing Market Snippet by Disease Category
- 2.1.4. Polygenic Risk Score Testing Market Snippet by Application
- 2.1.5. Polygenic Risk Score Testing Market Snippet by End User
- 2.1.6. Polygenic Risk Score Testing Market Snippet by Country
- 2.1.7. Polygenic Risk Score Testing Market Snippet by Region
2.2. Competitive Insights

3. Polygenic Risk Score Testing Key Market Trends

3.1. Polygenic Risk Score Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Polygenic Risk Score Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Polygenic Risk Score Testing Market Opportunities
3.4. Polygenic Risk Score Testing Market Future Trends

4. Polygenic Risk Score Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Polygenic Risk Score Testing Market : Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Polygenic Risk Score Testing Market Landscape

6.1. Polygenic Risk Score Testing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Polygenic Risk Score Testing Market - By Service Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Service Type, 2025 & 2033 (%)
- 7.1.2. Sequencing Services
- 7.1.3. Genotyping Services
- 7.1.4. Data Analysis and Interpretation
- 7.1.5. Software / Platforms
- 7.1.6. Reporting Solutions
- 7.1.7. Others

8. Polygenic Risk Score Testing Market - By Sample Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Sample Type, 2025 & 2033 (%)
- 8.1.2. Saliva
- 8.1.3. Buccal Swab
- 8.1.4. Blood
- 8.1.5. Others

9. Polygenic Risk Score Testing Market - By Disease Category

9.1. Overview
- 9.1.1. Segment Share Analysis, By Disease Category, 2025 & 2033 (%)
- 9.1.2. Cancer
- 9.1.3. Cardiovascular Diseases
- 9.1.4. Neurodegenerative Disorders
- 9.1.5. Genetic Diseases
- 9.1.6. Others

10. Polygenic Risk Score Testing Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Sample Type, 2025 & 2033 (%)
- 10.1.2. Disease Risk Assessment
- 10.1.3. Research
- 10.1.4. Personalized Medicine
- 10.1.5. Others

11. Polygenic Risk Score Testing Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 11.1.2. Hospitals and Clinics
- 11.1.3. Research Institutes
- 11.1.4. Pharmaceutical and Biotech Companies
- 11.1.5. Others

12. Polygenic Risk Score Testing Market - By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Polygenic Risk Score Testing Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Polygenic Risk Score Testing Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Denmark Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Denmark Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Denmark Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
  - 12.3.19.1. Overview
  - 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.19.3. Rest of the Europe Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.19.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.3.19.5. Rest of the Europe Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.3.19.6. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Polygenic Risk Score Testing Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Taiwan Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Taiwan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Taiwan Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
  - 12.4.18.1. Overview
  - 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.18.3. Vietnam Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.18.4. Vietnam Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.18.5. Vietnam Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.18.6. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
  - 12.4.19.1. Overview
  - 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.19.3. Rest of APAC Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.19.4. Rest of APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.4.19.5. Rest of APAC Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.4.19.6. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Polygenic Risk Score Testing Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Polygenic Risk Score Testing Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Iran Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Iran Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Iran Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
  - 12.6.16.1. Overview
  - 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.16.3. Qatar Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.16.4. Qatar Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.16.5. Qatar Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.6.16.6. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
  - 12.6.17.1. Overview
  - 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.17.3. Rest of MEA Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.17.4. Rest of MEA Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  - 12.6.17.5. Rest of MEA Market Size and Forecast, By Disease Category, 2020 - 2033 (US$ Million)
  - 12.6.17.6. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Polygenic Risk Score Testing Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. 23andMe
- 13.2.2. Myriad Genetics
- 13.2.3. Color Genomics
- 13.2.4. Quest Diagnostics
- 13.2.5. Illumina
- 13.2.6. Invitae Corporation
- 13.2.7. F. Hoffmann-La Roche
- 13.2.8. Thermo Fisher Scientific
- 13.2.9. Eurofins Scientific
- 13.2.10. BGI Genomics
- 13.2.11. Ambry Genetics
- 13.2.12. Centogene
- 13.2.13. Natera
- 13.2.14. QIAGEN
- 13.2.15. Personalis
- 13.2.16. Others

14. 360 Degree AnalystView

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us